Biodel: A Beaten Down Biotech Trading At A Large Discount
Biodel is a beaten down biotech stock that is currently trading at a large discount to net cash. The company is pursuing strategic alternatives that I believe will result in a reverse merger.
from Biotech News
0 Comments